RecruitingPhase 2

Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study

United States364 participantsStarted 2025-09-11

Plain-language summary

This study evaluates the effectiveness of a Shared Decision-Making (SDM) toolkit designed to support older breast cancer survivors aged 80 and above in making informed decisions about continuing surveillance mammography.

Who can participate

Age range80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓≥ 12 months since most recent breast surgery to affected breast (e.g., breast reduction surgery on an unaffected breast within 12 months is ok)

What they're measuring

Mammography Rate

Timeframe: Assessed at 2 years post-enrollment.

Trial details

NCT IDNCT07123649

SponsorDana-Farber Cancer Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-09-11

Contact for this trial

Rachel Freedman, MD, MPH

617-632-4587 Rachel_freedman@dfci.harvard.edu

View on ClinicalTrials.gov More Breast Cancer trials